Abstract
Background: Complementary and alternative medicine (CAM) use is common among patients with cardiovascular disorders and is generally underrecognized by physicians. The attitudes of these patients regarding these therapies and their perceptions of safety and efficacy have not been well defined.
Methods: A written survey was received from a cohort of outpatients seen at a large outpatient cardiovascular clinic in Texas. Over 75% of patients responded, with more than 90% of returned surveys adequate for analysis.
Results: Of the 210 respondents 113 admitted to CAM use, with Vitamins E and C being the most frequently utilized agents. Women were significantly more likely to take CAM than men (69 vs. 46%, p = 0.002), particularly those taking hormone replacement therapy. Over half of patients surveyed stated their cardiologist was unaware of their use of CAM. Only 15% of patients felt that CAM was more efficacious than their traditional medications, but almost half felt it was significantly safer. A similar number were unaware of any interactions between CAM and their other medications.
Conclusions: Use of CAM is common in cardiology outpatients, and many patients remain unaware of potential health risks. Physicians should routinely question patients about use of CAM and attempt to educate users regarding potential health risks.
Keywords: complementary and alternative medicine, cardiovascular disease, vitamin E, hormone replacement, safety, efficacy
Full Text
The Full Text of this article is available as a PDF (24.3 KB).
References
- 1. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC: Trends in alternative medicine use in the United States, 1990–1997: Results of a follow‐up national survey. J Am Med Assoc 1998; 280: 1569–1575 [DOI] [PubMed] [Google Scholar]
- 2. Gaytan RJ, Prisant LM: Oral nutritional supplements and heart disease: A review. Am J Ther 2001; 8: 255–274 [DOI] [PubMed] [Google Scholar]
- 3. Samenu KD, Link MS, Homoud MK, Contreras R, Theoharides TC, Wang PJ, Estes NAIII, Theohardes TC: Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 2002; 77: 12–16 [DOI] [PubMed] [Google Scholar]
- 4. Wilkinson S, Gomella LG, Smith JA, Brawer MK, Dawson NA, Wajsman Z, Dai L, Chodak GW: Attitudes and use of complementary medicine in men with prostate cancer. J Urol 2002; 168: 2505–2509 [DOI] [PubMed] [Google Scholar]
- 5. Lindsay BD: Are serious adverse cardiovascular events an unintended consequence of the Dietary Supplement Health and Education Act of 1994? Mayo Clin Proc 2002; 77: 7–9 [DOI] [PubMed] [Google Scholar]
- 6. Liu EH, Turner LM, Lin SX, Klaus L, Choi LY, Whitworth J, Ting W, Oz MC: Use of alternative medicine by patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2000; 120: 335–341 [DOI] [PubMed] [Google Scholar]
- 7. Turnheim K: Drug therapy in the elderly. Exp Gerontol 2004; 39: 1731–1738 [DOI] [PubMed] [Google Scholar]
- 8. Chagan L, Ioselovich A, Asherova L, Cheng JW: Use of alternative pharmacotherapy in management of cardiovascular diseases. Am J Manag Care 2002; 8: 270–285; quiz 286–288 [PubMed] [Google Scholar]
- 9. Baldwin CM, Long K, Kroesen K, Brooks AJ, Bell IR: A profile of military veterans in the southwestern United States who use complementary and alternative medicine: Implications for integrated care. Arch Intern Med 2002; 162: 1697–1704 [DOI] [PubMed] [Google Scholar]
- 10. Ai AL, Bolling SF: The use of complementary and alternative therapies among middle‐aged and older cardiac patients. Am J Med Qual 2002; 17: 21–27 [DOI] [PubMed] [Google Scholar]
- 11. Stys T, Stys A, Kelly P, Lawson W: Trends in use of herbal and nutritional supplements in cardiovascular patients. Clin Cardiol 2004; 27: 87–90 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Miller VM, Shuster LT, Hayes SN: Controversy of hormone treatment and cardiovascular function: Need for strengthened collaborations between pre‐clinical and clinical scientists. Curr Opin Investig Drugs 2003; 4: 1220–1232 [PubMed] [Google Scholar]
- 13. Lin MC, Nahin R, Gershwin ME, Longhurst JC, Wu KK: State of complementary and alternative medicine in cardiovascular, lung, and blood research: Executive summary of a workshop. Circulation 2001; 103: 2038–2041 [DOI] [PubMed] [Google Scholar]
- 14. Krasuski RA, Doeppenschmidt D, Henry JS, Smith PB, Adinaro J, Beck R, Thompson CM: Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: The CAPISH study. Mayo Clin Proc 2005; 80: 1163–1168 [DOI] [PubMed] [Google Scholar]
- 15. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P: Vitamin E supplementation and cardiovascular events in high‐risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 154–160 [DOI] [PubMed] [Google Scholar]
- 16. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high‐risk individuals : A randomised placebo‐controlled trial. Lancet 2002; 360: 23–33 [DOI] [PubMed] [Google Scholar]
- 17. Miller ER III, Pastor‐Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E: Meta‐analysis: High‐dosage vitamin E supplementation may increase all‐cause mortality. Ann Intern Med 2005; 142: 37–46 [DOI] [PubMed] [Google Scholar]